(Q34974856)

5 August 2017

1 reference

title

The therapeutic potential of the cannabinoids in neuroprotection (English)

1 reference

5 August 2017

0 references

Robert I Grundy

1

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Expert Opinion on Investigational Drugs

5 August 2017

published in

1 reference

5 August 2017

volume

11

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

1365-1374

1 reference

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cannabinoids and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cannabinoid receptor localization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cannabinoid CB1 Receptor Expression in Rat Spinal Cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cannabinoid receptors and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

The cannabinoid system and cytokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-Δ6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates receptor-mediated neurotoxicity in primary cultures of rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cerebral ischemia and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Tetrahydrocannabinol for tremor in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Nabilone in the treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cannabinoids control spasticity and tremor in a multiple sclerosis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

The role of cannabinoids in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and mu-opioid receptor binding in the basal ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Pharmacological interventions for stroke: failures and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.10.1365

10.1517/13543784.11.10.1365

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference